| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000037644 |
| Receipt No. | R000041607 |
| Scientific Title | Development and validation of system to predict risk of complications |
| Date of disclosure of the study information | 2019/08/26 |
| Last modified on | 2020/03/19 (Ver. 3) |
| Basic information | ||
| Public title | Development and validation of system to predict risk of complications | |
| Acronym | Development and validation of system to predict risk of complications | |
| Scientific Title | Development and validation of system to predict risk of complications | |
| Scientific Title:Acronym | Development and validation of system to predict risk of complications | |
| Region |
|
|
| Condition | |||
| Condition | Aspiration pneumonia | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To verify the effectiveness of patient care using artificial intelligence to control complications in hospitalized patients |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Number of patients with onset of aspiration pneumonia before and after the demonstration experiment |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |||
| No. of arms | 1 | ||
| Purpose of intervention | Prevention | ||
| Type of intervention |
|
||
| Interventions/Control_1 | Each of the following are performed three times a day:
*Enhanced oral care *Increasing the angle of the bed *Breathing training *Training on the intra-abdominal pressure *Postural change |
||
| Interventions/Control_2 | |||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients hospitalized for 4 days or more | |||
| Key exclusion criteria | Patients hospitalized within 3 days | |||
| Target sample size | 1000 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kitahara International Hospital | ||||||
| Division name | Department of Pharmacy | ||||||
| Zip code | 192-0045 | ||||||
| Address | 1-7-23, Owada-machi, Hachioji, Tokyo | ||||||
| TEL | 042-645-1110 | ||||||
| teppei_shimizu@kitaharahosp.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Kitahara International Hospital | ||||||
| Division name | Department of Pharmacy | ||||||
| Zip code | 192-0045 | ||||||
| Address | 1-7-23, Owada-machi, Hachioji, Tokyo | ||||||
| TEL | 042-645-1110 | ||||||
| Homepage URL | |||||||
| teppei_shimizu@kitaharahosp.com | |||||||
| Sponsor | |
| Institute | Kitahara International Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kitahara International Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | NEC Corporation |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Kitahara International Hospital |
| Address | 1-7-23, Owada-machi, Hachioji, Tokyo |
| Tel | 042-645-1110 |
| jun_nagai@kitaharahosp.com | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041607 |